Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Chetasi Talati, MD, Andrew Kuykendall, MD, Jori Kaplan, MD, Jose D Sandoval-Sus, MD, Samir Dalia, MD, Bijal D. Shah, MD, Celeste M. Bello, MD, Farhad Khimani, MD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, Julio C. Chavez, MD

Blood (2016) 128 (22): 1870.

https://doi.org/10.1182/blood.V128.22.1870.1870

Published: 2016

Journal Articles

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Patrick T. Griffin, MD, Samir Dalia, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Eduardo M. Sotomayor, MD, Julio C Chavez, MD

Blood (2014) 124 (21): 2981.

https://doi.org/10.1182/blood.V124.21.2981.2981

Published: 2014

Journal Articles

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Bijal D. Shah, MD, Jianguo Tao, MD PhD, Paul A. Chervenick, MD, Marcie L Riches, MD MS, Javier Pinilla-Ibarz, MD PhD, Lynn C. Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, MD, Sophie Dessureault, MD

Blood (2014) 124 (21): 3083.

https://doi.org/10.1182/blood.V124.21.3083.3083

Published: 2014

Journal Articles

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Patrick T. Griffin, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Lubomir Sokol, MD PhD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Jianguo Tao, MD PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD

Blood (2014) 124 (21): 4424.

https://doi.org/10.1182/blood.V124.21.4424.4424

Published: 2014

Journal Articles

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Lubomir Sokol, MD, Ph.D, Jianguo Tao, MD, PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD

Blood (2013) 122 (21): 5057.

https://doi.org/10.1182/blood.V122.21.5057.5057

Published: 2013

Journal Articles

A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Bryan J Little, MPH, Najla H Al Ali, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Ji-Hyun Lee, PhD, Kate Fisher, MA, Zachary Thompson, PhD, Bong-jin Choi, MA, Bijal D. Shah, MD

Blood (2013) 122 (21): 4267.

https://doi.org/10.1182/blood.V122.21.4267.4267

Published: 2013

Journal Articles

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Bijal D. Shah, MD, Jianguo Tao, MD, PhD, Lubomir Sokol, MD, PhD, Paul A. Chervenick, MD, Marcie Tomblyn, MD, MS, Javier Pinilla-Ibarz, MD, PhD, Lynn Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, Sophie Dessureault, MD

Blood (2011) 118 (21): 3720.

https://doi.org/10.1182/blood.V118.21.3720.3720

Published: 2011

Journal Articles

Evaluation of the Mantle Cell Lymphoma International Prognostic Index (MIPI) as An Indicator of Overall Survival, Progression Free Survival, Survival From Relapse

Bijal D. Shah, MD, Jennifer L. Cultrera, MD, Lubomir Sokol, MD, PhD, Paul A. Chervenick, MD, Celeste M. Bello, MD, Elizabeth M. Sagatys, MD, Lynn C. Moscinski, MD, Ling Zhang, MD, Jianguo Tao, MD, PhD, Eduardo M. Sotomayor, MD

Blood (2010) 116 (21): 5082.

https://doi.org/10.1182/blood.V116.21.5082.5082

Published: 2010

Journal Articles

Plasmablastic Lymphoma: A Series of 16 Cases with the Largest Collection of 9 HIV-Negative Cases

Jijun Liu, MD, Ling Zhang, MD, Ernesto Ayala, MD, Teresa Field, MD, PhD, Jose L. Ochoa-Bayona, MD, Lia Perez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Salvador Bruno, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD, PhD

Blood (2010) 116 (21): 4162.

https://doi.org/10.1182/blood.V116.21.4162.4162

Published: 2010

Journal Articles

Increase in Circulating Stem Cells in Patients With Myelofibrosis

Paul A. Chervenick

Blood (1973) 41 (5): 744.

https://doi.org/10.1182/blood.V41.5.744.744

Published: 1973

Journal Articles

Increase in Circulating Stem Cells in Patients With Myelofibrosis

Paul A. Chervenick, M.D.

Blood (1973) 41 (1): 67–71.

https://doi.org/10.1182/blood.V41.1.67.67

Published: 1973

Journal Articles

The Effect of Postirradiation Bleeding or Endotoxin on Proliferation and Differentiation of Hematopoietic Stem Cells

Sallie S. Boggs, Paul A. Chervenick, Dane R. Boggs

Blood (1972) 40 (3): 375–389.

https://doi.org/10.1182/blood.V40.3.375.375

Published: 1972

Journal Articles

Patterns of Proliferation and Differentiation of Hematopoietic Stem Cells After Compartment Depletion

PAUL A. CHERVENICK, M.D., DANE R. BOGGS, M.D.

Blood (1971) 37 (5): 568–580.

https://doi.org/10.1182/blood.V37.5.568.568

Published: 1971

Journal Articles

In Vitro Growth of Granulocytic and Mononuclear Cell Colonies From Blood of Normal Individuals

PAUL A. CHERVENICK, M.D., DANE R. BOGGS, M.D.

Blood (1971) 37 (2): 131–135.

https://doi.org/10.1182/blood.V37.2.131.131

Published: 1971

NARROW

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Evaluation of the Mantle Cell Lymphoma International Prognostic Index (MIPI) as An Indicator of Overall Survival, Progression Free Survival, Survival From Relapse

Plasmablastic Lymphoma: A Series of 16 Cases with the Largest Collection of 9 HIV-Negative Cases

Increase in Circulating Stem Cells in Patients With Myelofibrosis

Increase in Circulating Stem Cells in Patients With Myelofibrosis

The Effect of Postirradiation Bleeding or Endotoxin on Proliferation and Differentiation of Hematopoietic Stem Cells

Patterns of Proliferation and Differentiation of Hematopoietic Stem Cells After Compartment Depletion

In Vitro Growth of Granulocytic and Mononuclear Cell Colonies From Blood of Normal Individuals

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only